Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
RFL — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.83

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

1.11

Target Price

Analyst Recom

Performance Q

-44.97

Upside

-785.5%

Beta

0.72

Ticker: RFL



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-14RFL1.390.190.7910903
2026-10-15RFL1.450.16999.9910703
2026-10-16RFL1.380.090.0010037
2026-10-19RFL1.290.030.006813
2026-10-20RFL1.320.030.006797
2026-10-21RFL1.280.030.006797
2026-10-22RFL1.260.030.006797
2026-10-23RFL1.280.030.006797
2026-10-26RFL1.180.030.006767
2026-10-27RFL1.2850.030.006765
2026-10-28RFL1.250.030.006765
2026-10-29RFL1.130.030.006765
2026-10-30RFL1.10.030.006765
2026-11-02RFL1.010.030.006765
2026-11-03RFL1.110.030.006767
2026-11-04RFL1.090.030.006767
2026-11-05RFL1.050.030.006791
2026-11-06RFL1.020.030.006801
2026-11-09RFL1.080.030.006801
2026-11-10RFL1.060.030.006936
2026-11-11RFL1.120.030.006936
2026-11-12RFL1.08390.030.006936
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-14RFL1.41- - -
2026-10-15RFL1.47- - -
2026-10-16RFL1.38- - -
2026-10-19RFL1.29- - -
2026-10-20RFL1.29- - -
2026-10-21RFL1.30- - -
2026-10-22RFL1.27- - -
2026-10-23RFL1.29- - -
2026-10-26RFL1.18- - -
2026-10-27RFL1.29- - -
2026-10-28RFL1.25- - -
2026-10-29RFL1.13- - -
2026-10-30RFL1.08- - -
2026-11-02RFL1.00- - -
2026-11-03RFL1.16- - -
2026-11-04RFL1.09- - -
2026-11-05RFL1.07- - -
2026-11-06RFL1.01- - -
2026-11-09RFL1.13- - -
2026-11-10RFL1.07- - -
2026-11-11RFL1.12- - -
2026-11-12RFL1.11- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-14RFL0.004.772.25
2026-10-15RFL0.004.772.25
2026-10-16RFL0.004.772.25
2026-10-19RFL0.004.802.25
2026-10-20RFL0.004.802.25
2026-10-21RFL0.004.802.25
2026-10-22RFL0.004.802.25
2026-10-23RFL0.004.802.25
2026-10-26RFL0.004.802.25
2026-10-27RFL0.004.800.99
2026-10-28RFL0.004.800.99
2026-10-29RFL0.004.800.99
2026-10-30RFL0.004.800.99
2026-11-02RFL0.004.790.99
2026-11-03RFL0.004.790.99
2026-11-05RFL0.004.790.99
2026-11-06RFL0.004.790.99
2026-11-09RFL0.004.380.99
2026-11-10RFL0.004.380.99
2026-11-11RFL0.004.380.83
2026-11-12RFL0.004.380.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

4.38

Beta

0.72

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

46

Growth Score

29

Sentiment Score

92

Actual DrawDown %

83.9

Max Drawdown 5-Year %

-85.3

Target Price

P/E

Forward P/E

PEG

P/S

65.69

P/B

0.86

P/Free Cash Flow

EPS

-0.58

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3390.73

Relative Volume

0.19

Return on Equity vs Sector %

-51.4

Return on Equity vs Industry %

-51.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ RFL Real Estate
$1.10
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
19/25
Volume
11/15
Valuation
6/20
TP/AR
2/10
Options
7/10
RSI
35.8
Range 1M
17.3%
Sup Dist
2.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
21 /100
WEAK
Momentum
0/25
Growth
8/30
Estimates
1/20
Inst/Vol
4/15
Options
8/10
EPS Yr
0%
EPS NY
0%
52W%
3.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
6/30
Valuation
2/30
Growth
3/25
Stability
7/10
LT Trend
1/5
Quality
46
Click a card to see score breakdown Full Analysis →
RFL — P/E HistoricalBiotechnology
Rafael Holdings, Inc.
Sector: Real Estate
Industry: Real Estate Services
Employees: 15
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C (NPC), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate. The company is also involved in developing Promitil, a pegylated liposomal mitomycin-C lipidic prodrug which is designed molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form. In addition, it develops surgical and procedural devices, including orthopedic arthroscopy instrument for carpal and cubital tunnel syndrome. Further, the company provides technological solutions specifically engineered for increased bioavailability of cannabinoids. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
RFL

Latest News

—
Caricamento notizie per RFL…
stock quote shares RFL – Rafael Holdings Inc Stock Price stock today
news today RFL – Rafael Holdings Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch RFL – Rafael Holdings Inc yahoo finance google finance
stock history RFL – Rafael Holdings Inc invest stock market
stock prices RFL premarket after hours
ticker RFL fair value insiders trading